These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The survival outcome and patterns of failure in node positive endometrial cancer patients treated with surgery and adjuvant radiotherapy with curative intent. Rajasooriyar C; Bernshaw D; Kondalsamy-Chennakesavan S; Mileshkin L; Narayan K J Gynecol Oncol; 2014 Oct; 25(4):313-9. PubMed ID: 25142629 [TBL] [Abstract][Full Text] [Related]
3. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy. Murphy KT; Rotmensch J; Yamada SD; Mundt AJ Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437 [TBL] [Abstract][Full Text] [Related]
4. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691 [TBL] [Abstract][Full Text] [Related]
5. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy. Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964 [TBL] [Abstract][Full Text] [Related]
6. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy. Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094 [TBL] [Abstract][Full Text] [Related]
7. Endometrioid adenocarcinoma of the uterus: surgico-pathological correlations and role of pelvic lymphadenectomy. Chee JJ; Ho TH; Tay EH; Low JJ; Yam KL Ann Acad Med Singap; 2003 Sep; 32(5):670-5. PubMed ID: 14626800 [TBL] [Abstract][Full Text] [Related]
8. Nomogram to Predict Risk of Lymph Node Metastases in Patients With Endometrioid Endometrial Cancer. Pollom EL; Conklin CM; von Eyben R; Folkins AK; Kidd EA Int J Gynecol Pathol; 2016 Sep; 35(5):395-401. PubMed ID: 26598977 [TBL] [Abstract][Full Text] [Related]
9. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases]. Ma SK; Zhang HT; Sun YC; Wu LY Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912 [TBL] [Abstract][Full Text] [Related]
10. FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Bristow RE; Zahurak ML; Alexander CJ; Zellars RC; Montz FJ Int J Gynecol Cancer; 2003; 13(5):664-72. PubMed ID: 14675352 [TBL] [Abstract][Full Text] [Related]
11. Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma. Mueller JJ; Pedra Nobre S; Braxton K; Alektiar KM; Leitao MM; Aghajanian C; Ellenson LH; Abu-Rustum NR Gynecol Oncol; 2020 Jun; 157(3):619-623. PubMed ID: 32247604 [TBL] [Abstract][Full Text] [Related]
12. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis. Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study. Tal O; Eitan R; Gemer O; Helpman L; Vaknin Z; Leytes S; Lavie O; Ben-Arie A; Amit A; Namazov A; Ben Shahar I; Atlas I; Bruchim I; Levy T Int J Gynecol Cancer; 2021 Nov; 31(11):1437-1442. PubMed ID: 34725243 [TBL] [Abstract][Full Text] [Related]
14. Role of adjuvant therapy in stage IIIC2 endometrial cancer. Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864 [TBL] [Abstract][Full Text] [Related]
15. Impact of body mass index on surgical outcomes and analysis of disease recurrence for patients with endometrial cancer undergoing robotic-assisted staging. Menderes G; Azodi M; Clark L; Xu X; Lu L; Ratner E; Schwartz PE; Rutherford TJ; Santin AD; Silasi DA Int J Gynecol Cancer; 2014 Jul; 24(6):1118-25. PubMed ID: 24927247 [TBL] [Abstract][Full Text] [Related]
17. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137 [TBL] [Abstract][Full Text] [Related]
18. Is Surgical Staging Necessary for Patients with Low-risk Endometrial Cancer? A Retrospective Clinical Analysis. Kokcu A; Kurtoglu E; Celik H; Kefeli M; Tosun M; Onal M Asian Pac J Cancer Prev; 2015; 16(13):5331-5. PubMed ID: 26225674 [TBL] [Abstract][Full Text] [Related]
19. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573 [TBL] [Abstract][Full Text] [Related]
20. Analysis of patients with stage IIIC endometrial cancer. Turan T; Ureyen I; Duzguner I; Ozkaya E; Tasci T; Karalok A; Boran N; Kose MF; Tulunay G Int J Gynecol Cancer; 2014 Jul; 24(6):1033-41. PubMed ID: 24905617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]